Dose Finding Study of GH21 in Adult Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2025-02-20
Target enrollment:
Participant gender:
Summary
Evaluate the safety and tolerability of GH21 in patients with advanced solid tumors.
Estimate the maximum tolerated dose (MTD) in patients with advanced solid tumors.